Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lillie James Woodruff
Chief Scientific Officer at MapLight Therapeutics. Filing since 15 Apr 2026.
CIK 0001728746
Company
Date
Role
Action
Shares
Amount
Of holding
MPLT
MapLight Therapeutics, Inc.
3 Aug 2026
Chief Scientific Officer
Sold on a plan
22,082
$276.91K
9.8%
MPLT
MapLight Therapeutics, Inc.
17 Jul 2026
Chief Scientific Officer
Sold at will
2,077
$78.72K
0.9%
MPLT
MapLight Therapeutics, Inc.
16 Jul 2026
Chief Scientific Officer
Sold at will
8,547
$314.41K
3.6%
MPLT
MapLight Therapeutics, Inc.
15 Jul 2026
Chief Scientific Officer
Sold at will
7,643
$280.51K
3.1%
MPLT
MapLight Therapeutics, Inc.
7 May 2026
Chief Scientific Officer
Sold on a plan
721
$20.39K
0.3%
MPLT
MapLight Therapeutics, Inc.
6 May 2026
Chief Scientific Officer
Sold on a plan
24,811
$713.60K
9.2%
MPLT
MapLight Therapeutics, Inc.
5 May 2026
Chief Scientific Officer
Sold on a plan
11,095
$312.84K
4.0%
MPLT
MapLight Therapeutics, Inc.
4 May 2026
Chief Scientific Officer
Sold on a plan
15,801
$441.81K
5.4%
MPLT
MapLight Therapeutics, Inc.
16 Apr 2026
Chief Scientific Officer
Sold at will
2,783
$76.18K
0.9%
MPLT
MapLight Therapeutics, Inc.
15 Apr 2026
Chief Scientific Officer
Sold at will
1,730
$46.40K
0.6%
10 decisions on file.
